News
Cryoprecipitate, REBOA Flop for Improving Major Hemorrhage Outcomes — The first randomized trials of both approaches failed by Crystal Phend , Contributing Editor, MedPage Today October 13, 2023 ...
Addition of early cryoprecipitate vs standard care did not improve all-cause 28-day mortality in the intent-to-treat population (25.3% vs 26.1%; P = .74).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback